Symbols / TARS Stock $62.98 +3.36% Tarsus Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • NMS
TARS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. Bobak R. Azamian M.D.
Exch · Country NMS · United States
Market Cap 2.68B
Enterprise Value 2.26B
Income -66.42M
Sales 451.36M
FCF (ttm) -164.00K
Book/sh 8.07
Cash/sh 9.80
Employees 370
Insider 10d —
IPO Oct 16, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 21.57
PEG —
P/S 5.94
P/B 7.80
P/C —
EV/EBITDA -32.66
EV/Sales 5.00
Quick Ratio 3.72
Current Ratio 3.85
Debt/Eq 24.18
LT Debt/Eq —
EPS (ttm) -1.59
EPS next Y 2.92
EPS Growth —
Revenue Growth 128.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-23
ROA -9.45%
ROE -23.39%
ROIC —
Gross Margin 78.95%
Oper. Margin -5.26%
Profit Margin -14.71%
Shs Outstand 42.56M
Shs Float 32.26M
Insider Own 3.14%
Instit Own 108.03%
Short Float 11.07%
Short Ratio 10.37
Short Interest 4.56M
52W High 85.25
vs 52W High -26.13%
52W Low 38.51
vs 52W Low 63.53%
Beta 0.63
Impl. Vol. 46.01%
Rel Volume 0.20
Avg Volume 571.55K
Volume 113.75K
Target (mean) $94.22
Tgt Median $95.00
Tgt Low $88.00
Tgt High $100.00
# Analysts 9
Recom Strong_buy
Prev Close $60.93
Price $62.98
Change 3.36%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-0.07
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest TARS news

No recent news from Yahoo. Try the RSS feed for latest TARS news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-20 NEERVANNAN SESHADRI Chief Operating Officer — 2,989 $66.75 $199,516
2026-03-19 WHITFIELD DIANNE C Officer — 12,274 $67.00 $839,070
2026-03-19 WAHL BRYAN General Counsel — 12,440 $67.00 $850,417
2026-03-19 LIN ELIZABETH YEU Officer — 1,144 $67.00 $78,204
2026-03-19 FARROW JEFFREY S Chief Financial Officer — 6,430 $67.00 $439,566
2026-03-19 MOTTIWALA AZIZ Officer — 13,056 $67.00 $892,528
2026-03-19 NEERVANNAN SESHADRI Chief Operating Officer — 11,324 $67.00 $772,444
2026-03-19 AZAMIAN BOBAK R Chief Executive Officer — 34,603 $67.00 $2,364,904
2026-03-16 LINK WILLIAM J Director — 12,500 $68.09 $859,819
2026-03-13 WHITFIELD DIANNE C Officer — 23,909 — —
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category